Management of Post-transplant Hyperparathyroidism and Bone Disease

Significant advances in immunosuppressive therapies have been made in renal transplantation, leading to increased allograft and patient survival. Despite improvement in overall patient survival, patients continue to require management of persistent post-transplant hyperparathyroidism. Medications th...

Descripción completa

Detalles Bibliográficos
Autores principales: Delos Santos, Rowena, Rossi, Ana, Coyne, Daniel, Maw, Thin Thin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439149/
https://www.ncbi.nlm.nih.gov/pubmed/30811012
http://dx.doi.org/10.1007/s40265-019-01074-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439149/
https://www.ncbi.nlm.nih.gov/pubmed/30811012
http://dx.doi.org/10.1007/s40265-019-01074-4

Ejemplares similares